Abbott Laboratories Buys Piramal's India Unit For $3.72 Billion

The Abbott logo stands outside one of its facilities in Des Plaines, Illinois, U.S., on Friday, May 21, 2010. Abbott Laboratories will buy Piramal Healthcare Ltd.�s branded generic-medicine unit in India for $3.72 billion, becoming the country's biggest drugmaker and tapping into a market expected to more than double by 2015. Photographer: Tim Boyle/Bloomberg via Getty Images
The Abbott logo stands outside one of its facilities in Des Plaines, Illinois, U.S., on Friday, May 21, 2010. Abbott Laboratories will buy Piramal Healthcare Ltd.�s branded generic-medicine unit in India for $3.72 billion, becoming the country's biggest drugmaker and tapping into a market expected to more than double by 2015. Photographer: Tim Boyle/Bloomberg via Getty Images
Abbott Laboratories Buys Piramal's India Unit For $3.72 Billion
PURCHASE A LICENSE
How can I use this image?
$499.00
USD

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
100116174
Collection:
Bloomberg
Date created:
May 21, 2010
Upload date:
License type:
Release info:
Not released. More information
Source:
Bloomberg
Object name:
ABBOTT BUYS PIRAMAL GENERICS